Mediators of Inflammation (Jan 2016)

The Role of Interleukin-17 in Lung Cancer

  • Feng Wu,
  • Juanjuan Xu,
  • Qi Huang,
  • Jieli Han,
  • Limin Duan,
  • Jinshuo Fan,
  • Zhilei Lv,
  • Mengfei Guo,
  • Guorong Hu,
  • Lian Chen,
  • Shuai Zhang,
  • Xiaonan Tao,
  • Wanli Ma,
  • Yang Jin

DOI
https://doi.org/10.1155/2016/8494079
Journal volume & issue
Vol. 2016

Abstract

Read online

Tumour-associated inflammation is a hallmark of malignant carcinomas, and lung cancer is a typical inflammation-associated carcinoma. Interleukin-17 (IL-17) is an important inflammatory cytokine that plays an important role in chronic inflammatory and autoimmune diseases and in inflammation-associated tumours. Numerous studies have shown that IL-17 directly or indirectly promotes tumour angiogenesis and cell proliferation and that it inhibits apoptosis via the activation of inflammatory signalling pathways. Therefore, IL-17 contributes to the metastasis and progression of lung cancer. Research advances with respect to the role of IL-17 in lung cancer will be presented as a review in this paper.